Britain aims to roll out an injection that can treat hundreds of cancer patients in just 7-minutes. The NHS said that atezolizumab, also known as Tecentric, is usually given to patients through a drip directly into their veins. This takes about 30 minutes or an hour for some patients.
London: For the first time in World, Britain is going to become the first country in the world to inject cancer patients within seven minutes. Britain’s public National Health Service (NHS) is set to become the first in the world to treat hundreds of cancer patients in the country with a single injection, cutting treatment time by three quarters.
Hundreds of cancer patients being treated with immunotherapy are now being prepared to be given injections of atezolizumab “under the skin”, the NHS said on Tuesday after receiving approval from the British Medicines and Healthcare products Regulatory Agency (MHRA). Is. This will reduce the time for cancer treatment.
The NHS said that atezolizumab, also known as Tecentric, is usually given to patients through a drip directly into their veins. This process takes about 30 minutes or up to an hour for some patients.
In many patients, this time also takes longer, when it becomes difficult for the medicine to reach their veins, but with the new method, now this medicine will be injected under the skin instead of intravenously. England would be the first country to do so. Tecentric is a monoclonal antibody that affects the functions of the body’s immune system in cancer patients.
According to official sources, Dr Alexander Martin, consultant oncologist at West Suffolk NHS Foundation Trust, said: “This approval will not only allow us to deliver more convenient and faster care for our patients, but will also allow our teams to treat more patients throughout the day.” Will enable.” “It takes about seven minutes, compared to 30 to 60 minutes with the current drip method,” said Marius Scholtz, medical director of Roche Products Ltd.
Atezolizumab, which has been the backbone of Roche company Genentech, is an immunotherapy drug that empowers patients’ immune systems to find and destroy cancer cells. Currently, the treatment is offered to patients suffering from various types of cancer, including lung, breast, liver and bladder cancer.